What did Needham change in the LIVN analyst rating on February 25, 2026?

Needham maintained LivaNova PLC at **Buy** on February 25, 2026 and raised the price target to **$81**. The note was published at 12:09 PM and showed a **0.56% ($0.39)** price move at issuance.

How should investors interpret a maintained Buy with a higher price target for LIVN?

A maintained Buy with a higher target means the analyst is more optimistic about valuation but unchanged on risk profile. Investors should watch execution on guidance, margin progress, and key milestones tied to the new target.

Does the LIVN analyst rating change mean other analysts will follow?

Not necessarily. Needham’s raise signals confidence, but other firms will wait for confirmatory results such as revenue delivery and clinical updates before revising ratings or targets.

What is Meyka AI’s view of LivaNova after this LIVN analyst rating update?

Meyka AI rates LIVN **B+**, reflecting relative strength against benchmarks, sector trends, growth, and analyst consensus. This is a data-driven grade and not investment advice.

Analyst Ratings

Needham Maintains Buy on LivaNova PLC (LIVN) Feb 25, 2026 PT Raised to $81

ByHuzaifa Zahoor February 26, 2026February 26, 2026

Needham maintained a Buy rating on LivaNova PLC (LIVN) and raised its price target to $81 on February 25, 2026 at 12:09 PM. The Livanova note, published by StreetInsider, lists the action as a maintained Buy with an increased target, a move that signals continued analyst confidence in the company’s trajectory. This LIVN analyst rating update comes alongside recent Q4 2025 results and 2026 guidance, which together shape the near-term outlook for investors.